Jean-Pierre Nordmann

MedTech executive with 20 years of experience driving strategy, market expansion, and operational transformation across healthcare providers and technology companies in France, Sweden, and Europe. I operate at the intersection of healthcare systems, innovation, and growth, leading high-impact initiatives from design to execution in complex and regulated environments. I began my career in 2005 as a consultant supporting hospitals, MedTechs, public authorities, and private equity funds on high-stakes projects. Over the years, I delivered measurable outcomes, including: – a €100M hospital transformation plan designed and executed with leadership teams, – the acceleration of a MedTech scale-up generating double-digit annual growth, – strategic due-diligence assignments; – performance improvements in hospital operations reducing costs by 8–12% depending on service lines. After becoming Senior Manager at EY, I founded my own consulting team, growing it to 10 employees in 3 years, repeatedly ranked “Excellent” by Leaders League for operational performance and transformation programs. In 2022, I joined the Executive MBA at the Stockholm School of Economics, deepening my expertise in negotiation, international expansion, and financial leadership (ranked #1 in my cohort), as well as scaling high-growth organizations. I later co-founded Closar AI, securing early-stage VC financing (€150k for 10% equity) and leading early clinical validation in France and Sweden. I currently lead Market Expansion and Strategic Growth for QUMEA in France, a Swiss MedTech leveraging AI-powered radar technology to transform patient safety and mobility monitoring.QUMEA’s solution enables continuous, non-intrusive monitoring for fall prevention, wandering detection, and pressure ulcer risk, already deployed in 130+ hospitals and care facilities across Europe. France is now emerging as one of its fastest-growing markets. My role focuses on structuring and accelerating market adoption in a €3B+ target market by: – building and closing national strategic partnerships with leading healthcare groups and public stakeholders, – driving market access and commercial development, – overseeing internal and external operations in France (clinical, technical, and deployment teams), – securing pilots and scaling deployments across major hospital networks, – positioning QUMEA as a trusted partner for healthcare transformation at scale.